Literature DB >> 11955958

A selective decrease in the relative density of parvalbumin-immunoreactive neurons in the hippocampus in schizophrenia.

Zhi Jun Zhang1, Gavin P Reynolds.   

Abstract

Neuropathological studies have demonstrated deficits of GABAergic interneurons in the hippocampus in schizophrenia. and selective deficits in some GABAergic sub-populations defined by calcium-binding proteins (CBPs) have been reported in the cortex in schizophrenia. In the present study, the relative densities of cells immunoreactive for the CBPs parvalbumnin (PV) and calretinin (CR) were determined in hippocampal tissue sections taken from patients with schizophrenia, bipolar disorder and major depression and from matched control subjects (15 per group). No significant difference in the density of CR-immunoreactive neurons was found between subject groups. Relative to normal controls, schizophrenic patients showed a significant and profound deficit in the relative density of PV-immunoreactive neurons in all hippocampal sub-fields. These reductions were more apparent in male than female schizophrenic patients, and were unrelated to antipsychotic drug treatment, age or duration of illness. The density of PV-immunoreactive neurons did not differ significantly from controls in the depression group, although a trend toward decreased relative density of PV-immunoreactive neurons was apparent in bipolar disorder that reached significance in one sub-field. The findings provide further evidence to support a profound and selective abnormality of a sub-population of GABAergic neurons in the hippocampus in schizophrenia.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11955958     DOI: 10.1016/s0920-9964(01)00188-8

Source DB:  PubMed          Journal:  Schizophr Res        ISSN: 0920-9964            Impact factor:   4.939


  173 in total

Review 1.  Hippocampal neurons in schizophrenia.

Authors:  S Heckers; C Konradi
Journal:  J Neural Transm (Vienna)       Date:  2002-05       Impact factor: 3.575

Review 2.  Gene-environment interplay in schizopsychotic disorders.

Authors:  Tomas Palomo; Trevor Archer; Richard M Kostrzewa; Rrichard J Beninger
Journal:  Neurotox Res       Date:  2004       Impact factor: 3.911

Review 3.  The hippocampus in schizophrenia: a review of the neuropathological evidence and its pathophysiological implications.

Authors:  Paul J Harrison
Journal:  Psychopharmacology (Berl)       Date:  2004-03-06       Impact factor: 4.530

4.  NMDAR antagonist action in thalamus imposes δ oscillations on the hippocampus.

Authors:  Yuchun Zhang; Takashi Yoshida; Donald B Katz; John E Lisman
Journal:  J Neurophysiol       Date:  2012-03-14       Impact factor: 2.714

5.  Bipolar disorder type 1 and schizophrenia are accompanied by decreased density of parvalbumin- and somatostatin-positive interneurons in the parahippocampal region.

Authors:  Alice Y Wang; Kathryn M Lohmann; C Kevin Yang; Eric I Zimmerman; Harry Pantazopoulos; Nicole Herring; Sabina Berretta; Stephan Heckers; Christine Konradi
Journal:  Acta Neuropathol       Date:  2011-10-04       Impact factor: 17.088

Review 6.  Developmental pathology, dopamine, stress and schizophrenia.

Authors:  Daniel J Lodge; Anthony A Grace
Journal:  Int J Dev Neurosci       Date:  2010-08-19       Impact factor: 2.457

7.  Loss of microRNAs in pyramidal neurons leads to specific changes in inhibitory synaptic transmission in the prefrontal cortex.

Authors:  Ruby Hsu; Claude M Schofield; Cassandra G Dela Cruz; Dorothy M Jones-Davis; Robert Blelloch; Erik M Ullian
Journal:  Mol Cell Neurosci       Date:  2012-06-20       Impact factor: 4.314

8.  Treatment with levetiracetam improves cognition in a ketamine rat model of schizophrenia.

Authors:  Ming Teng Koh; Yi Shao; Sharon Rosenzweig-Lipson; Michela Gallagher
Journal:  Schizophr Res       Date:  2017-06-17       Impact factor: 4.939

9.  Evidence of multistability in a realistic computer simulation of hippocampus subfield CA1.

Authors:  Peter J Siekmeier
Journal:  Behav Brain Res       Date:  2009-06-08       Impact factor: 3.332

Review 10.  Review of pathological hallmarks of schizophrenia: comparison of genetic models with patients and nongenetic models.

Authors:  Hanna Jaaro-Peled; Yavuz Ayhan; Mikhail V Pletnikov; Akira Sawa
Journal:  Schizophr Bull       Date:  2009-11-10       Impact factor: 9.306

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.